Table 1.
Comparison of chemo sensitivity in sorafenib-sensitive and sorafenib-resistant cells with different mtTXNRD3 expression levels.
| Compound | Cell Lines & IC50 (Mean ± SD) | p Value | |
|---|---|---|---|
|
Doxorubicin (μM) |
MV4-11 IC50 = 0.54 ± 0.11 | MV4-11R IC50 = 2.57 ± 0.16 |
0.0004 |
| SK-Hep1VC IC50 = 0.99 ± 0.06 |
SK-Hep1OE IC50 = 3.42 ± 0.30 |
0.0014 |
|
| Ara-C (μM) | MV4-11 IC50 = 0.86 ± 0.12 |
MV4-11R IC50 = 3.35 ± 0.18 |
0.0003 |
| SK-Hep1VC IC50 = 0.56 ± 0.06 |
SK-Hep1OE IC50 = 1.48 ± 0.18 |
0.0091 | |
The data were the results of three separate experiments. Each experiment was done in triplicate. The statistical significance of the difference between sorafenib-sensitive (low mtTXNRD3 expression) and sorafenib-resistant (high mtTXNRD3 expression) cells was analyzed using Student t-test.